key: cord-0717298-z0lt111o
authors: Ahmed Mahmoud Gad, Elshafie; Elshafie Ahmed, Mohamed; Al-Fahemi, Jabir H.
title: Comparative study on quantum descriptors, Molecular docking and dynamic simulation of antiviral drugs with Covid-19
date: 2021-01-21
journal: nan
DOI: 10.1016/j.ejpe.2021.01.002
sha: f69833b48561be7e2a02b2f8151e18a83e8d2194
doc_id: 717298
cord_uid: z0lt111o

Covid-19 is a beta-coronavirus that was first identified during the Wuhan COVID-19 epidemic in 2019. This study is focused on the quantum descriptors of the proposed antiviral drugs, molecular docking, and dynamics simulation with the main protease of coronavirus. Such drugs are Baloxavir, Chloroquine, Avigan, Plaquenil, oseltamivir, Remdesivir, Arbidol, and Sofosbuvir were used for comparison. Density functional theory (DFT) may help find the relevancy of quantum chemical descriptors to explain the potential antiviral activity, Some quantum descriptors such as ΔE; the energy gap, η; global hardness, S; global softness, I: ionization potential, A: electron affinity, χ: absolute electronegativity, ω; ΔE Back-donation; the back donation were calculated based on EHOMO; energy of the highest occupied molecular orbital, and ELUMO; energy of the lowest unoccupied molecular orbital. Fukui indices (f+, f-); for local nucleophilic and electrophilic attacks are investigated for the investigated antiviral drugs. The reported genomic sequence of Covid-19 main protease in complex with an inhibitor N3 (DOI: 10.2210/pdb6LU7/pdb) was used as a precursor for docking with the selected drugs after removing the attached inhibitors N3 and water. Molecular docking was performed using Autodock 4.2, with the Lamarckian Genetic Algorithm, and was analyzed by Autodock 1.5.6 and Pymol version 1.7.4.5 Edu, However, further research is necessary to investigate their potential medicinal use.

Coronaviruses can be classified into four genera: Alphacoronavirus, Beta-coronavirus, Gammacoronavirus, and Delta-coronavirus. Among them, alpha-and beta-coronaviruses infect mammals, gamma-coronaviruses infect avian species, and delta-coronaviruses infect both mammalian and avian species [1] . Structure, Function and Evolution of Coronavirus Spike Proteins were reviewed [2] . In general, coronaviruses COVID-19 infects humans causing a variety of highly prevalent and severe diseases, including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) [3] . Its main protease (Mpro) plays an important role in viral replication and transcription. So, it can be an attractive drug target for this virus [4] . Virtual drug screening was carried out to identify new drug leads that target the COVID-19 virus main protease (Mpro) [1] . Different compounds were tested against Covid-19 [5] including Sofosbuvir, IDX-184, Ribavirin, Remissive, Guanosine triphosphate (GTP), Uracil triphosphate (UTP), Cinnamaldehyde, and Thymoquinone, Chloroquine was reported to be strong in vitro and in vivo antiviral activities against HCoVOC43 [6] . Sofosbuvir, Ribavirin, and Remissive can be used against the new strain of coronavirus that emerged with promising results. GTP derivatives may be used as specific inhibitors against COVID-19 [5] . Avigan (Favipiravir) was reported that it can be a substitute for compassionate use in COVID-19 based on its mechanism of action inhibiting virus RdRp [7] . Modification of oseltamivir was investigated as a neuraminidase inhibitor of influenza A virus subtype H1N1 [8] . Based on molecular docking, three molecules out of 67 natural product extracts pronounce to be SARS-CoV-2 antiviral [9] . Up till now, no antiviral therapy or vaccine is available against coronavirus infection and attempts in this trend are accelerated to combat the current epidemic outbreak [10] , [11] Binding site analysis of potential protease inhibitors of COVID-19 were determined using AutoDock [16] . It is of interest to investigate eight of FDA approved drugs (i.e., (Baloxavir [12] , Chloroquine [6, 7] , Avigan [7] , Plaquenil [14] , oseltamivir [8] , Remdesivir [11] , Arbidol [15] , and Sofosbuvir [5] ) to be docked to the main protease structure of Covis-19 for understanding their potential antiviral activity against the new epidemic coronavirus. The selected drugs Baloxavir, Chloroquine Avigan, Plaquenil, oseltamivir, Remdesivir, Arbidol, and Sofosbuvir are designated L1, L2, L3, L4, L5, L6, L7 and L8, respectively.

The COVID-19 main protease's crystallographic structure was recently made publicly available through the Protein Data Bank (PDB) as a complex with an N3 inhibitor (PDB ID: 6lu7) [2, 15] . By using Autodock4.2, water and associated inhibitor chain were removed from the (pdb) file, then hydrogen and Kollman charges were added to the protein, then the (pdb) file was saved as (pdbqt) file. The structure of the approved drug was retrieved from PubChem [18] as a 3D conformer and saved as (sdf) file, then generated to a (pdb) file using Discovery Studio visualizer v 20.1.0.

All quantum descriptors are calculated using ORCA 4.0 applying functional B3LYP OPT def2-TZVP/J NormalPrint Grid4 Normal SCF [19] , with Avogadro 1.2 as Graphical user interface GUI. The obtained HOMO and LUMO orbitals for the selected drugs can be visualized in Figure 1 and their energy EHOMO and ELUMO values are listed in Table 1 .

The following descriptors [20] ; the energy gap; Egap = (ELUMO  EHOMO) , Ionization potential;

(I =  EHOMO), electron affinity; (A =  ELUMO), the electronegativity; ( = (I+A)/2)), global hardness; ( = (IA)/2)), and softness (S = 1/), can be calculated based on the energy of the HOMO and the LUMO [22] , The local reactivity of ligand molecules is analyzed using Fukui's indices [23] .

The sequance of docking is explained in supplementary text (A) Autodock 1.5.6 used for protein optimization, by removing water and other atoms, then adding a polar hydrogen group [24] . Ligand tethering of the protein was performed by regulating the genetic algorithm (GA) parameters, using 10 runs [25] . The default force-field parameters for these atom types can be overridden using the "parameter file" command in the GPF and DPF. This command requires one argument, namely the filename of the ".dat" file that contains the linear free energy model's coefficients and the atom parameters; the default values can be found in "AD4_parameters.dat" which resides in the source code distribution. All of the conformations obtained from the molecular docking were energy-minimized using molecular mechanics (MM) force-field. MD simulations were then applied to multiple conformations of the protein-ligand complexes. Among the 10 highest-scoring docking poses saved for each compound. The obtained protein-ligand complexes with the optimum binding energy were analyzed using Pymol [26] .

The frontier molecular orbitals of selected drugs are graphical represented in Figure 1 . The highest-energy occupied (HOMO) and lowest-energy unoccupied molecular orbitals (LUMO).

HOMO is logically viewed as nucleophilic or electron donating, while the LUMO is electrophilic and electron accepting [27] , According to the obtained EHOMO and ELUMO as shown in Table 1 The values of the energy gap are listed in Table 1 . The energy bandgap (Egap), the difference between ELUMO and EHOMO is an indication of the reactivity of the molecules [28] . Accordingly, the smaller Egap is the more reactive molecule towards docking. So, the global reactivities of the Table 1 shows values of the ionization potential of the investigated drugs. The lower ionization energy of L4 (Plaquenil) 5.29 (eV) indicates that it is the more reactive one out of the investigated drugs. a good nucleophile can be characterized by low values of chemical potential  [27, 29] . It is clear from the chemical potential values in Table 1 that the Avigan (L3) shows the lower chemical potential.

Fukui functions f+ and f-are calculated to analyze the chemically active sites of a molecule using the following equations:

f-= qN+1 -qN for nucleophilic attack (1) f += qN -qN-1 for electrophilic attack (2) where qN is the Mullikan atomic charge for neutral molecule, qN+1 the Mullikan atomic charge for positively charged molecule and qN-1 the Mullikan atomic charge for negatively charged molecule.

The local reactivity of the molecule is analyzed using condensed Fukui indices (as attached supplementary Table 3 are negative values ranging from -3.7 kCal/mol to -7.08 kCal/mol. For all ligands tested the mean RMSD are 0.0 Å. Lower RMSD value of the complex indicates its stability with the investigated drugs and provided a suitable basis for this study. The binding free energy was attributed to the Gvdw, Ghbond, Gelec, Gtor and Gsol and can be expressed in the following equation:

The obtained molecular docking analysis and visualization using PyMol of Covid-19

binding with the investigated ligands ( Table 4 with their binding sites can be characterized in terms of a binding affinity. In general, high-affinity ligand binding results from greater intermolecular force between the ligand and its receptor while low-affinity ligand binding involves less intermolecular force between the ligand and its receptor.

Several parameters may indicate more potential antiviral activity of Avigan than the other 

Virtual Screening based prediction of potential drugs for COVID-19

Structure, Function, and Evolution of Coronavirus Spike Proteins

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

Anti-HCV, nucleotide inhibitors, repurposing against COVID-19

Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice

Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1

Moroccan Medicinal plants as inhibitors of COVID-19: Computational investigations

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

Remdesivir in adults with severe COVID-19: a randomised, doubleblind, placebo-controlled, multicentre trial

Baloxavir: First Global Approval

Of chloroquine and COVID-19

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Main point : Hydroxychloroquine was found to be more potent than chloroquine at inhibiting SARS-CoV-2 in vit

Discovering drugs to treat coronavirus disease 2019 (COVID-19)

Binding site analysis of potential protease inhibitors of COVID-19 using AutoDock

The protein data bank

PubChem 2019 update: Improved access to chemical data

Experimental and computational study of ecofriendly synthesized imine cationic surfactants as corrosion inhibitors for carbon steel in 1 M HCl

The corrosion inhibition of (2Z,2′Z)-4,4′-(1,2-phenylene bis(azanediyl))bis(4-oxobut-2-enoic acid) for carbon steel in acidic media using DFT

Theoretical approach for the performance of 4-mercapto-1-alkylpyridin-1-ium bromide as corrosion inhibitors using DFT

Removal of iron (II) from wastewater in oil field using 3-(p-methyl) phenyl-5-thionyl-1,2,4-triazoline assembled on silver nanoparticles

A genetic algorithm for the ligand-protein docking problem

Visualization of macromolecular structures

Adsorpitivity and corrosion inhibtion performance of 2-(alkyloxy)-N,N,N-tris(2-hydroxyethyl)-2-oxoethanaminium chloride using DFT Approach

Density functional theory, chemical reactivity, pharmacological potential and molecular docking of dihydrothiouracil-indenopyridopyrimidines with human-DNA topoisomerase II